e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
COPD: exacerbation and clinical problems
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Community-acquired pneumonia (CAP) in patients with chronic obstructive pulmonary disease (COPD)
S. Avdeev, G. Baimakanova, P. Zubairova, A. Chuchalin (Moscow, Russian Federation)
Source:
Annual Congress 2009 - COPD: exacerbation and clinical problems
Session:
COPD: exacerbation and clinical problems
Session type:
Thematic Poster Session
Number:
3474
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Avdeev, G. Baimakanova, P. Zubairova, A. Chuchalin (Moscow, Russian Federation). Community-acquired pneumonia (CAP) in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 2009; 34: Suppl. 53, 3474
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Community-acquired pneumonia (CAP) in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003
Community-acquired pneumonia (CAP): differences between patients with chronic obstructive pulmonary disease (COPD) and those without COPD
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Does the condition of chronic obstructive pumonary disease (COPD) have a prognostic benefit in patients with community-acquired pneumonia (CAP)?
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003
Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB)
Source: Eur Respir J 2006; 28: Suppl. 50, 395s
Year: 2006
COPD is associated with increased mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 346-351
Year: 2006
Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients
Source: Eur Respir J 2012; 39: 855-861
Year: 2012
Viral infections as a cause of chronic obstructive pulmonary disease (COPD) exacerbations
Source: Annual Congress 2009 - Exacerbations of COPD: new findings
Year: 2009
Mycoplasma pneumoniae infection and acute exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Infection as a comorbidity of COPD
Source: Eur Respir J 2010; 35: 1209-1215
Year: 2010
Community-acquired pneumonia as a cause of acute respiratory failure (ARF) in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 518s
Year: 2005
How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients?
Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients
Year: 2015
Antibiotics in the exacerbations of severe and very severe chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Prognosis after non-invasive ventiltation (NIV) for chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure
Year: 2011
Impact of anemia in patients admitted due to a chronic obstructive pulmonary disease (COPD) exacerbation.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Bacterial infection-a common cause of acute exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 576s
Year: 2006
The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP)
Source: International Congress 2014 – Clinical presentations
Year: 2014
Use of antibiotics in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009
Can chronic obstructive lung disease (COPD) criteria be used to manage bronchiectasis (BR) and obliterative bronchiolitis (OB) in children surviving severe lung infection?
Source: Eur Respir J 2001; 18: Suppl. 33, 172s
Year: 2001
Genomic variability of
haemophilus
in patients with COPD
Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept